Perfusion computed tomography to assist decision making for stroke thrombolysis


The use of perfusion imaging to guide selection of patients for stroke thrombolysis remains controversial because of lack of supportive phase three clinical trial evidence. We aimed to measure the outcomes for patients treated with intravenous recombinant tissue plasminogen activator (rtPA) at a comprehensive stroke care facility where perfusion computed… (More)
DOI: 10.1093/brain/awv071


6 Figures and Tables

Slides referencing similar topics